Rosti buys Alvi Group, adding 400 staff and €50M in revenue
What's the deal? Rosti GroupDealroom has a profile for this one. Try Dealroom →, the Malmö-based plastic injection moulding and contract manufacturer, has acquired Alvi Group for undisclosed terms. The deal, which closed on November 2, 2026, adds Alvi's five sites in Norway, Sweden, Poland and China plus about 400 employees.
What changes? Rosti now has roughly 3,000 employees and combined revenue of €450 million, with Alvi contributing €50 million. The acquisition adds Norway to Rosti's footprint and expands its operations in Sweden, Poland and China.
Why now? The deal follows Rosti's recent investment in medical capacity, including a 500-square-metre ISO Class 8 cleanroom opened in China in April 2026. It fits a broader push to build regulated, cleanroom-based production closer to customers.
What's the endgame? Rosti serves medical, consumer and industrial customers, turning concepts into finished products. Alvi's customers gain access to Rosti's global network, engineering and R&D resources, while Rosti's customers benefit from Alvi's regional expertise and stronger medical device capabilities.
The acquired sites now operate as Rosti Norway, Rosti Sweden, Rosti Poland and Rosti China. In Leksvik, toolmaker Industriverktøy continues as Rosti Industriverktøy.
"This acquisition strengthens Rosti," said Jonas Persson, chief executive officer of Rosti Group. "Combined with our existing operations across USA, Europe and Asia, we can now serve our customers even more comprehensively."
Magnus Emeus, chief executive officer of Alvi Group, said Rosti has "the platform, resources and market presence to take what we've built to a higher level."
The signal: The deal reflects strategic interest in regulated medical manufacturing. Kimball Solutions bought medical micro-moulder Helvoet in July, and Kohlberg acquired medical-components maker Ingenyx in August — though Rosti's undisclosed price makes its financial impact hard to assess.
Read more: prnewswire.com
Image credit: jurvetson
